Filipe Santos Pereira-Dutra

13PUBLICATIONS
53CO-AUTHORS
Molecular targetsNanotoxicology, health and safetyMedical infection agents (incl. prions)Biologically active moleculesMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 08, 2025
Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice.

Mayara Mattos, Carolina Q Sacramento, André C Ferreira

|Nov 14, 2024
Cannabinoid receptor type 2 agonist GP1a attenuates macrophage activation induced by M. bovis-BCG by inhibiting NF-κB signaling.

Jessica Do Prado Valeriano, Magaiver Andrade-Silva, Filipe Pereira-Dutra

|May 10, 2024
Accumulation of lipid droplets induced by Listeria monocytogenes in macrophages: implications for survival and evasion of innate immunity.

Filipe S Pereira-Dutra, Ellen K Souza, Tamyris S Souza

|Jan 13, 2023
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation.

Thiago Moreno L Souza, Vagner D Pinho, Cristina F Setim

|Dec 29, 2022
Mycobacterium tuberculosis induces delayed lipid droplet accumulation in dendritic cells depending on bacterial viability and virulence.

Maria Fernanda de Souza Costa, Filipe Pereira-Dutra, Nathalie Deboosere

|Jul 27, 2022
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones.

Otávio Augusto Chaves, Natalia Fintelman-Rodrigues, Xuanting Wang

Pageof 3

Frequent Collaborators

8 joint publications

Patricia T Bozza

5 joint publications

Jairo Ramos Temerozo

4 joint publications

Dumith Chequer Bou-Habib

3 joint publications

Natalia Fintelman-Rodrigues